SEDOR PHARMACEUTICALS is targeting investment opportunities in the biopharmaceutical industry with the following characteristics:

Structure

Acquisition of company, product portfolio, or manufacturing facility; Product licensing agreement

Stage

Launched, near-launch, or early stage with low-development risk

Financials

Licensed products with funding needs, underperforming or non-strategic assets producing revenues

Products

Branded specialty segments with promotional sensitivity and/or generics with growth opportunity

Geography

North American and European markets

Exit

Mid-term timeframe (2-5 years) in sectors attractive to strategic buyers